(Q34698848)

4 August 2017

1 reference

title

Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches (English)

1 reference

4 August 2017

0 references

Speight TM

1

1 reference

PubMed ID

4403890

4 August 2017

Avery GS

series ordinal

2

1 reference

4 August 2017

1 January 1972

1 reference

4 August 2017

1 reference

4 August 2017

3

1 reference

4 August 2017

3

1 reference

4 August 2017

159-203

1 reference

Effect of cyproheptadine on the electrical activity of the hypothalamic feeding centres.

4 August 2017

1 reference

12 December 2020

Thyroid-Hormone Enhancement of Imipramine in Nonretarded Depressions

1 reference

12 December 2020

[Mechanism of the appetite and body weight increasing effect of cyproheptadine. I. Clinical experience and hormone iodine studies].

1 reference

12 December 2020

Prostaglandin E-1: a potential mediator of the inflammatory response

1 reference

12 December 2020

[Effects of a serotonin antagonist (BC 105 Sandoz) on carbohydrate metabolism]

1 reference

12 December 2020

Long-term therapy of persistent migraine with BC-105

1 reference

12 December 2020

A comparative trial of serotonin antagonists in the management of migraine

1 reference

12 December 2020

Migraine as a cyclic disease with latent and overt components--effects with an antaminic drug

1 reference

12 December 2020

BC 105 in the prophylaxis of migraine

1 reference

12 December 2020

The action of BC-105 in chronic schizophrenics with depression.

1 reference

12 December 2020

Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

1 reference

12 December 2020

Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105

1 reference

12 December 2020

An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences.

1 reference

12 December 2020

Appraisal of BC-105 in migraine prophylaxis

1 reference

12 December 2020

Nitrolglycerin as a provocative agent in cluster headache

1 reference

12 December 2020

Comparative trial of serotonin antagonists in the management of migraine

1 reference

12 December 2020

The treatment of migraine with BC 105 (pizotifen): a double blind trial

1 reference

12 December 2020

MAST CELLS AND THEIR ACTIVE SUBSTANCES: THEIR ROLE IN THE PATHOGENESIS OF MIGRAINE

1 reference

12 December 2020

The control of flushing and diarrhoea in carcinoid syndrome by an antiserotonin agent, BC105

1 reference

12 December 2020

[Mechanism of the appetite and body weight increasing effect of cyproheptadine. 3. Changes in lipid metabolism]

1 reference

12 December 2020

Effects of prostaglandins on function and cyclic AMP levels of human blood platelets

1 reference

12 December 2020

Conjugation Defect in Tyramine-sensitive Migraine

1 reference

12 December 2020

Relationships between headache and amine changes after administration of reserpine to migrainous patients

1 reference

12 December 2020

Thermographic, hormonal and clinical studies in migraine

1 reference

12 December 2020

Clinical trial of a new serotonin antagonist, BC105, in the prevention of migraine.

1 reference

12 December 2020

Dietary Migraine and Tyramine Metabolism

1 reference

12 December 2020

Uptake, metabolism, storage, and release of 5-hydroxytryptamine in blood platelets

1 reference

12 December 2020

BC-105--a new serotonin antagonist in the treatment of migraine.

1 reference

12 December 2020

The effect of cyproheptadine on food consumption in the fasted rat

1 reference

12 December 2020

Cyproheptadine, an antihistamine and serotonin antagonist acting on body weight: preliminary report

1 reference

12 December 2020

Effect of Cyproheptadine on Appetite and Weight Gain in Adults

1 reference

12 December 2020

A preliminary report on BC-105: a new antidepressant

1 reference

12 December 2020

Clinical and metabolic effects of different doses of prostaglandin E1 in man. Prostaglandin and related factors

1 reference

12 December 2020

A clinical trial of an antiserotonin drug, bc-105 in the prophylaxis of migraine

1 reference

12 December 2020

BC-105 a new preparation for the interval treatment of migraine--a double blind evaluation compared with a placebo

1 reference

12 December 2020

Cluster migraine--an unrecognized common entity

1 reference

12 December 2020

Interval treatment of migraine with BC 105, a new serotonin antagonist

1 reference

12 December 2020

Preliminary report on tyramine headache

1 reference

12 December 2020

Mechanisof the appetite and body weight increasing effect of cyproheptadine. II. Changes in carbohydrate metabolism

1 reference

12 December 2020

Trial of a serotonin inhibitor BC 105 in the prevention of migraine.

1 reference

12 December 2020

[Vasoneuroactive substance, antiaminic BC-105 and migraine]

1 reference

12 December 2020

A humoral agent implicated in vascular headache of the migraine type

1 reference

12 December 2020

Experiences with the new serotonin antagonist BC-105 (Sandomigran) in the treatment of migraine

1 reference

12 December 2020

Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache

1 reference

12 December 2020

BC 105 and methysergide (Deseril) in migraine prophylaxis

1 reference

12 December 2020

Chronic migrainous neuralgia--diagnostic and therapeutic aspects

1 reference

12 December 2020

Antiarrhythmic actions of BC 105

1 reference

12 December 2020

Migraine: a pulmonary disease?

1 reference

12 December 2020

Plasma Serotonin in Migraine and Stress

1 reference

12 December 2020

Effect of cyproheptadiae (periactin) on accumulation of (14C)5-hydroxytryptamine in pregnant rats

1 reference

12 December 2020

Identifiers

PubMed ID

4403890

1 reference

PubMed ID

4403890